62 related articles for article (PubMed ID: 8046241)
1. Adenosine and homocysteine together enhance TNF-mediated cytotoxicity but do not alter activation of nuclear factor-kappa B in L929 cells.
Bergmann S; Shatrov V; Ratter F; Schiemann S; Schulze-Osthoff K; Lehmann V
J Immunol; 1994 Aug; 153(4):1736-43. PubMed ID: 8046241
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase inhibitor S-adenosyl-L-homocysteine sensitizes human breast carcinoma MCF7 cells and related TNF-resistant derivatives to TNF-mediated cytotoxicity via the ceramide-independent pathway.
Shatrov VA; Ameyar M; Cai Z; Bettaieb A; Chouaib S
Eur Cytokine Netw; 1999 Jun; 10(2):247-52. PubMed ID: 10400831
[TBL] [Abstract][Full Text] [Related]
3. Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells.
Sen CK; Khanna S; Reznick AZ; Roy S; Packer L
Biochem Biophys Res Commun; 1997 Aug; 237(3):645-9. PubMed ID: 9299419
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphatase-dependent/tyrosine kinase-independent induction of nuclear factor-kappa B by tumor necrosis factor-alpha: effects on prostaglandin endoperoxide synthase-2 mRNA accumulation.
Mahboubi K; Young W; Ferreri NR
J Pharmacol Exp Ther; 1998 May; 285(2):862-8. PubMed ID: 9580637
[TBL] [Abstract][Full Text] [Related]
5. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy.
Higuchi Y; Otsu K; Nishida K; Hirotani S; Nakayama H; Yamaguchi O; Matsumura Y; Ueno H; Tada M; Hori M
J Mol Cell Cardiol; 2002 Feb; 34(2):233-40. PubMed ID: 11851362
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
7. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2873-80. PubMed ID: 9743348
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V
Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146
[TBL] [Abstract][Full Text] [Related]
9. Adenosine prevents activation of transcription factor NF-kappa B and enhances activator protein-1 binding activity in ischemic rat heart.
Li C; Ha T; Liu L; Browder W; Kao RL
Surgery; 2000 Feb; 127(2):161-9. PubMed ID: 10686981
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants.
Hughes G; Murphy MP; Ledgerwood EC
Biochem J; 2005 Jul; 389(Pt 1):83-9. PubMed ID: 15727562
[TBL] [Abstract][Full Text] [Related]
12. TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells.
Jobin C; Holt L; Bradham CA; Streetz K; Brenner DA; Sartor RB
J Immunol; 1999 Apr; 162(8):4447-54. PubMed ID: 10201981
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1.
Manna SK; Kuo MT; Aggarwal BB
Oncogene; 1999 Jul; 18(30):4371-82. PubMed ID: 10439045
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
Johns LD; Sarr T; Ranges GE
J Immunol; 1994 Jun; 152(12):5877-82. PubMed ID: 8207213
[TBL] [Abstract][Full Text] [Related]
15. Effects of antioxidants and NO on TNF-alpha-induced adhesion molecule expression in human pulmonary microvascular endothelial cells.
Jiang MZ; Tsukahara H; Hayakawa K; Todoroki Y; Tamura S; Ohshima Y; Hiraoka M; Mayumi M
Respir Med; 2005 May; 99(5):580-91. PubMed ID: 15823455
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
19. Effects of hypoxia on the cytotoxicity mediated by tumor necrosis factor-alpha.
Naldini A; Cesari S; Bocci V
Lymphokine Cytokine Res; 1994 Aug; 13(4):233-7. PubMed ID: 7999923
[TBL] [Abstract][Full Text] [Related]
20. Differential effects on growth, homocysteine, and related compounds of two inhibitors of S-adenosylhomocysteine catabolism, 3-deazaadenosine, and 3-deazaaristeromycin, in C3H/10T1/2 cells.
Djurhuus R; Svardal AM; Ueland PM
Cancer Res; 1989 Jan; 49(2):324-30. PubMed ID: 2910451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
